Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

Bluejay Diagnostics (BJDX) has entered into an Agreement to Amend the Master Service Agreement and the Master Supply Agreement with SanyoSeiko, a Japan-based contract manufacturer specializing in medical devices and precision engineering. The amended agreement was entered into in connection with Bluejay expanding SanyoSeiko’s role in helping to commercialize Bluejay’s Symphony platform, a near-patient testing system designed to provide results for key biomarkers such as IL-6 in sepsis management. Pursuant to statements of work that Bluejay has begun providing to Sanyoseiko under this agreement, Sanyoseiko will provide end-to-end support for the Symphony platform, managing raw material sourcing and vendor compliance, and serving as Bluejay’s contract manufacturing organization for analyzers, cartridges, and related components. In this capacity, Sanyoseiko will oversee fulfillment, kit assembly, labeling, packaging, shipping, and quality control of manufactured products, while also providing regulatory and quality management support, and equipment storage and maintenance.